Early or deferred initiation of efavirenz during rifampicin-based TB therapy has no significant effect on CYP3A induction in TB-HIV infected patients.

Autor:	Aklillu, Eleni1 (AUTHOR) eleni.aklillu@ki.se, Zumla, Alimuddin2,3 (AUTHOR), Habtewold, Abiy4 (AUTHOR), Amogne, Wondwossen5 (AUTHOR), Makonnen, Eyasu6 (AUTHOR), Yimer, Getnet6 (AUTHOR), Burhenne, Jürgen7 (AUTHOR), Diczfalusy, Ulf8 (AUTHOR)
Zdroj:	British Journal of Pharmacology. Aug2021, Vol. 178 Issue 16, p3294-3308. 15p. 1 Diagram, 3 Charts, 4 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu